scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1030370653 |
P356 | DOI | 10.1186/S13287-016-0395-Z |
P3181 | OpenCitations bibliographic resource ID | 2756225 |
P932 | PMC publication ID | 5084318 |
P698 | PubMed publication ID | 27793190 |
P2093 | author name string | Jun Xu | |
Wei Lu | |||
Yan Li | |||
Cheng Chen | |||
Limei Zhu | |||
Yan Shao | |||
Weiqing Shi | |||
XiaoDong Han | |||
P2860 | cites work | Avian influenza A (H9N2): computational molecular analysis and phylogenetic characterization of viral surface proteins isolated between 1997 and 2009 from the human population | Q21245109 |
Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes | Q21559413 | ||
Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies | Q28260818 | ||
Mesenchymal stem cells attenuate peritoneal injury through secretion of TSG-6 | Q28566510 | ||
Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1 | Q28757126 | ||
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production | Q29619807 | ||
Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. | Q30327047 | ||
Influenza A (H5N1) in Hong Kong: an overview. | Q30331157 | ||
Human pulmonary microvascular endothelial cells support productive replication of highly pathogenic avian influenza viruses: possible involvement in the pathogenesis of human H5N1 virus infection | Q30409253 | ||
Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection | Q30409432 | ||
Clinical research during a public health emergency: a systematic review of severe pandemic influenza management. | Q30427085 | ||
Factors associated with case fatality of human H5N1 virus infections in Indonesia: a case series | Q33360515 | ||
Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. | Q34143724 | ||
Inhibition of CK2α down-regulates Hedgehog/Gli signaling leading to a reduction of a stem-like side population in human lung cancer cells | Q34328051 | ||
First reported detection of a low pathogenicity avian influenza virus subtype H9 infection in domestic fowl in England | Q34403434 | ||
Different environmental drivers of highly pathogenic avian influenza H5N1 outbreaks in poultry and wild birds | Q34544962 | ||
Risk factors and characteristics of low pathogenic avian influenza virus isolated from commercial poultry in Tunisia | Q34551481 | ||
Effect of avian influenza A H5N1 infection on the expression of microRNA-141 in human respiratory epithelial cells | Q34714698 | ||
Mechanisms of submucosal gland morphogenesis in the airway. | Q35060126 | ||
Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus | Q35363365 | ||
Chemokines in acute respiratory distress syndrome | Q35980338 | ||
Innate immunity to H5N1 influenza viruses in humans | Q36482747 | ||
Seroepidemiological evidence of avian influenza A virus transmission to pigs in southern China | Q36559128 | ||
Microevolution of highly pathogenic avian influenza A(H5N1) viruses isolated from humans, Egypt, 2007-2011. | Q36584392 | ||
Gene-modified mesenchymal stem cells protect against radiation-induced lung injury | Q36673719 | ||
New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis: a potential role for stem cells in the lung parenchyma and implications for therapy. | Q36749464 | ||
Wharton's jelly-derived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications | Q37007214 | ||
Mesenchymal stem cells as immunomodulator therapies for immune-mediated systemic dermatoses | Q37921773 | ||
Lung injury in preterm neonates: the role and therapeutic potential of stem cells | Q37991744 | ||
Cellular and molecular interactions of mesenchymal stem cells in innate immunity | Q38059340 | ||
Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing | Q38073092 | ||
Comparison of serum treatments to remove nonspecific inhibitors from chicken sera for the hemagglutination inhibition test with inactivated H5N1 and H9N2 avian Influenza A virus subtypes | Q38460488 | ||
Clinical features of avian influenza in Egyptian patients | Q38881737 | ||
The pathogenicity and host immune response associated with H5N1 highly pathogenic avian influenza virus in quail | Q42285154 | ||
Antigenic and genetic characterization of a European avian-like H1N1 swine influenza virus from a boy in China in 2011. | Q43171592 | ||
Human infection with influenza H9N2. | Q43209306 | ||
Immune responses and protection against H5N1 highly pathogenic avian influenza virus induced by the Newcastle disease virus H5 vaccine in ducks | Q45352670 | ||
H5N1 virus activates signaling pathways in human endothelial cells resulting in a specific imbalanced inflammatory response | Q45371027 | ||
Identification of potential risk factors associated with highly pathogenic avian influenza subtype H5N1 outbreak occurrence in Lagos and Kano States, Nigeria, during the 2006-2007 epidemics. | Q46477204 | ||
A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies. | Q53107971 | ||
Preconditioning enhances the paracrine effect of mesenchymal stem cells in preventing oxygen-induced neonatal lung injury in rats | Q83991066 | ||
Human embryonic stem cell-derived hematopoietic cells maintain core epigenetic machinery of the polycomb group/Trithorax Group complexes distinctly from functional adult hematopoietic stem cells | Q84576581 | ||
Roles of Wnt/beta-catenin signaling in epithelial differentiation of mesenchymal stem cells | Q84824101 | ||
Spontaneous breathing with biphasic positive airway pressure attenuates lung injury in hydrochloric acid-induced acute respiratory distress syndrome | Q87657655 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | avian influenza | Q43987 |
acute lung injury | Q4677935 | ||
P304 | page(s) | 159 | |
P577 | publication date | 2016-10-28 | |
P1433 | published in | Stem Cell Research & Therapy | Q14390536 |
P1476 | title | Mesenchymal stromal cell treatment prevents H9N2 avian influenza virus-induced acute lung injury in mice | |
P478 | volume | 7 |
Q91922933 | A Review of SARS-CoV-2 and the Ongoing Clinical Trials |
Q99401090 | COVID-19 and its Therapeutics: Special Emphasis on Mesenchymal Stem Cells Based Therapy |
Q90536394 | Comparative Effects of Umbilical Cord- and Menstrual Blood-Derived MSCs in Repairing Acute Lung Injury |
Q91707486 | Current Status of Cell-Based Therapies for Respiratory Virus Infections: Applicability to COVID-19 |
Q59358581 | EMAPII Monoclonal Antibody Ameliorates Influenza A Virus-Induced Lung Injury |
Q38901248 | Fifty Years of Research in ARDS. Cell-based Therapy for Acute Respiratory Distress Syndrome. Biology and Potential Therapeutic Value. |
Q55280335 | IPSC‑MSC inhibition assessment in Raw 264.7 cells following oxygen and glucose deprivation reveals a distinct function for cardiopulmonary resuscitation. |
Q90074681 | MSC Based Therapies-New Perspectives for the Injured Lung |
Q47548197 | Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model |
Q37649042 | Mesenchymal stem cells alleviate Japanese encephalitis virus-induced neuroinflammation and mortality. |
Q94518099 | Mesenchymal stem cells as a potential therapy for COVID-19 |
Q94559488 | Mesenchymal stem/stromal cells: the therapeutic effects in animal models of acute pulmonary diseases |
Q96138639 | Novel therapeutic approaches for treatment of COVID-19 |
Q60938728 | TLR3 Regulated Poly I:C-Induced Neutrophil Extracellular Traps and Acute Lung Injury Partly Through p38 MAP Kinase |
Q47554935 | The role of adjuvant immunomodulatory agents for treatment of severe influenza |
Q99571376 | The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm |
Q64106024 | The therapeutic effects of bone marrow-derived mesenchymal stromal cells in the acute lung injury induced by sulfur mustard |
Search more.